Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Targeted cancer drugs can cause skin reactions, so dermatologists must manage these effects.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

Researchers identified promising inhibitors for the BRD4 protein, including finasteride and amentoflavone.

A bull with a gene mutation was asymptomatic, synthetic retinoids cause hair loss, and new therapeutic targets were identified for skin diseases.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Promising cancer treatments were found, but the manufacturer closed.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

New therapies for Birt–Hogg–Dubé syndrome are being developed based on understanding the FLCN gene's role.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

Gefitinib can cause hair and eyebrow darkening.

Ruxolitinib helped a woman with a genetic mutation regrow her hair and improved her health.

Talazoparib is more effective than standard chemotherapy for advanced breast cancer with BRCA mutations.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.